NCT01439386

Brief Summary

This prospective, multi-center, single blinded study aims to compare the influence of two different catheter ablation strategies, on long-term ablation outcome in terms of AF recurrence and quality of life (QoL) in patients presenting with coexistent AF and AFL. The two strategies to be evaluated are 1) the ablation of paroxysmal atrial fibrillation (PAF) with or without flutter (AFL) ablation (AF ± AFL) versus 2) AFL ablation alone.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
86

participants targeted

Target at below P25 for phase_3

Timeline
Completed

Started Sep 2011

Longer than P75 for phase_3

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

September 1, 2011

Completed
20 days until next milestone

First Submitted

Initial submission to the registry

September 21, 2011

Completed
2 days until next milestone

First Posted

Study publicly available on registry

September 23, 2011

Completed
1.8 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

July 1, 2013

Completed
3 years until next milestone

Study Completion

Last participant's last visit for all outcomes

July 1, 2016

Completed
Last Updated

October 19, 2017

Status Verified

October 1, 2017

Enrollment Period

1.8 years

First QC Date

September 21, 2011

Last Update Submit

October 17, 2017

Conditions

Outcome Measures

Primary Outcomes (1)

  • Recurrence of atrial arrhythmia

    Any episode of AF/AT longer than 30 sec will be considered as a recurrence. Episodes that occur during the first 3 months after the procedure (blanking period) will not be considered as recurrence.

    12 months

Secondary Outcomes (1)

  • Change in QoL score from baseline

    12 months

Study Arms (2)

AF ablation with or without AFL ablation

ACTIVE COMPARATOR

Pulmonary vein antral isolation (PVAI)with or without cavo-tricuspid isthmus (CTI) ablation

Procedure: Catheter ablation

AFL ablation only

ACTIVE COMPARATOR

Cavo-tricuspid isthmus ablation only

Procedure: Catheter ablation

Interventions

PVAI with or without CTI ablation

AF ablation with or without AFL ablation

Eligibility Criteria

Age18 Years - 75 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age: ≥ 18years
  • Patients presenting with paroxysmal AF and typical AFL
  • Ability to provide written, informed consent

You may not qualify if:

  • Reversible causes of atrial arrhythmia such as hyperthyroidism, pneumonia, pulmonary embolism, sarcoidosis and excessive alcohol consumption
  • Bleeding disorder
  • Contra-indication to anti-coagulants

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Texas Cardiac Arrhythmia Institute, St. David's Medical Center

Austin, Texas, 78705, United States

Location

Related Publications (2)

  • References: Symptomatic improvement after radiofrequency catheter ablation for typical atrial flutter; Heart 2001;86:167-171 Quality-of-Life in Patients With Paroxysmal Atrial Fibrillation After Catheter Ablation: Results of Long-Term Follow-Up; PACE 2003; 26:678-684 Quality of life restored to normal in patients with atrial fibrillation after pulmonary vein ostial Isolation; Am Heart J 2004;148:318-25 Effect of Left Atrial Ablation on the Quality of Life in Patients With Atrial Fibrillation; Circ J 2008; 72: 582-587 Catheter Ablation for Atrial Fibrillation in Congestive Heart Failure; N Engl J Med 2004;351:2373-83. Effects of Radiofrequency Catheter Ablation on Quality of Life in Patients With Atrial Flutter; Am J Cardiol 1999;84:278-283 Radiofrequency Catheter Ablation of Common Atrial Flutter : Significance of Palpitations and Quality-of-Life Evaluation in Patients With Proven Isthmus Block; Circulation 1999;99;534-540 Relationship Between Atrial Fibrillation and Typical Atrial Flutter in Humans; Circulation. 1997;96:3484-3491 Combining ablation of atrial fibrillation with ablation of atrial flutter: Are we there yet? JACC, Vol 43, No. 11, 2004 Factors predicting recurrences of atrial fibrillation after radiofrequency catheter ablation of typical atrial flutter; Seminars in Cardiology, 2003, vol. 9, No. 3: 55-60 Effectiveness of catheter ablation for coexisting atrial fibrillation and atrial flutter; Am J Cardiol 2004; 94:666-668 Quality of Life in Atrial Fibrillation: Measurement Tools and Impact of Interventions; J Cardiovasc Electrophysiol. 2008 July ; 19(7): 762-768 Clinical significance of inducible atrial flutter during pulmonary vein isolation in patients with atrial fibrillation. J Am Coll Cardiol. 2004 Jun 2;43(11):2057-62. Effectiveness of catheter ablation for coexisting atrial fibrillation and atrial flutter. Am J Cardiol. 2004 Sep 1;94(5):666-8.

    RESULT
  • Mohanty S, Mohanty P, Di Biase L, Bai R, Santangeli P, Casella M, Dello Russo A, Tondo C, Themistoclakis S, Raviele A, Rossillo A, Corrado A, Pelargonio G, Forleo G, Natale A. Results from a single-blind, randomized study comparing the impact of different ablation approaches on long-term procedure outcome in coexistent atrial fibrillation and flutter (APPROVAL). Circulation. 2013 May 7;127(18):1853-60. doi: 10.1161/CIRCULATIONAHA.113.001855. Epub 2013 Apr 9.

MeSH Terms

Interventions

Catheter Ablation

Intervention Hierarchy (Ancestors)

Radiofrequency AblationRadiofrequency TherapyTherapeuticsAblation TechniquesSurgical Procedures, Operative

Study Officials

  • Andrea Natale, MD

    Texas Cardiac Arrhythmia Research Foundation

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
phase 3
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Purpose
TREATMENT
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Executive medical director

Study Record Dates

First Submitted

September 21, 2011

First Posted

September 23, 2011

Study Start

September 1, 2011

Primary Completion

July 1, 2013

Study Completion

July 1, 2016

Last Updated

October 19, 2017

Record last verified: 2017-10

Locations